Utility of contrast enhanced intraoperative ultrasound with Sonazoid for patients with liver tumors

Utility of contrast enhanced intraoperative ultrasound with Sonazoid for patients with liver tumors - Sonazoid IOUS for liver tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003139

Enrollment

200

Registered

2010-02-04

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic liver tumors primary hepatic tumors

Interventions

Contrast enhanced intraoperative ultrasound using Sonazoid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing surgery for liver tumors

Exclusion criteria

Exclusion criteria: 1, Cardiac failure 2. Respiratory failure 3. Allergy for egg

Design outcomes

Primary

Measure	Time frame
1. Diagnostic ability to differentiate new lesions detected during conventional fundamental intraoperative ultrasound. 2. Frequency to find new hepatocellular carcinoma solely by contrast enhanced intraoperative ultrasound.	—

Countries

Japan

Contacts

Public ContactTakeshi Takamoto

Japanese Red Cross Medical Center Hepato-biliary-pancreatic surgery

takamoto@nifty.com03-3400-1311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026